Notch Signaling Pathway and Endocrine Resistance in Breast Cancer

Nearly 70% of breast cancers express the estrogen receptor (ER) and are hormone-dependent for cell proliferation and survival. Anti-estrogen therapies with aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs) or selective estrogen receptor down regulators (SERDs) are the standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Jing-Wen, Wei, Min, Li, Ji-Wei, Zhang, Guo-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318302/
https://www.ncbi.nlm.nih.gov/pubmed/32636747
http://dx.doi.org/10.3389/fphar.2020.00924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318302/
https://www.ncbi.nlm.nih.gov/pubmed/32636747
http://dx.doi.org/10.3389/fphar.2020.00924

Ejemplares similares